These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1197576)

  • 1. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
    Tilson HA; Baker TG; Gylys JA
    Psychopharmacologia; 1975 Nov; 44(3):225-8. PubMed ID: 1208758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.
    Penington NJ; Reiffenstein RJ
    Eur J Pharmacol; 1986 Apr; 122(3):373-7. PubMed ID: 3709659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat.
    Shannon HE
    Psychopharmacology (Berl); 1980; 67(3):311-2. PubMed ID: 6770411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA).
    Broadbent J; Appel JB; Michael EK; Ricker JH
    Behav Pharmacol; 1992 Oct; 3(5):443-454. PubMed ID: 11224147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5HT-2 mediation of acute behavioral effects of hallucinogens in rats.
    Wing LL; Tapson GS; Geyer MA
    Psychopharmacology (Berl); 1990; 100(3):417-25. PubMed ID: 2138338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the behavioral effects of DOM homologs.
    Glennon RA; Young R; Rosecrans JA
    Pharmacol Biochem Behav; 1982 Apr; 16(4):557-9. PubMed ID: 7071089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.
    Appel JB; Callahan PM
    Eur J Pharmacol; 1989 Jan; 159(1):41-6. PubMed ID: 2707301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
    Glennon RA; Young R; Soine W
    Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of behavioral properties of di- and tri-methoxyphenylisopropylamines.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 1982 Oct; 17(4):603-7. PubMed ID: 6965276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2008 Feb; 324(2):827-33. PubMed ID: 17993605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of MDA analogs.
    Glennon RA; Young R; Rosecrans JA; Anderson GM
    Biol Psychiatry; 1982 Jul; 17(7):807-14. PubMed ID: 6126227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.